# Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

> **NCT01056783** · PHASE2 · COMPLETED · sponsor: **Oxagen Ltd** · enrollment: 26 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** OC000459
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01056783
- **Lead sponsor:** Oxagen Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056783, "Proof of Concept Study of OC000459 in Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01056783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*